Detection of asymptomatic coronary artery disease using atherogenic proteins and acute phase reactants

Details for Australian Patent Application No. 2005217380 (hide)

Owner National Screening Institute, LLC

Inventors Bates, Harold M.

Agent Peter Maxwell & Associates

Pub. Number AU-B-2005217380

PCT Pub. Number WO2005/083446

Priority 10/777,543 12.02.04 US

Filing date 25 January 2005

Wipo publication date 9 September 2005

Acceptance publication date 19 August 2010

International Classifications

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

17 August 2006 PCT application entered the National Phase

  PCT publication WO2005/083446 Priority application(s): WO2005/083446

19 August 2010 Application Accepted

  Published as AU-B-2005217380

16 December 2010 Standard Patent Sealed

23 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005217383-Switch machine with switch point connectors

2005217375-Identification of cancer protein biomarkers using proteomic techniques